IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Vertex Pharmaceuticals Inc

CUSIP: 92532F10 | 8 institutional holders

Quarters

Q3 2016Q1 2016Q3 2015Q2 2015Q1 2015
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2016

Arrowstreet Capital, Limited Partnership5,500
0.0% of portfolio›$480
StyleTurnoverLocationFiled
Arrowstreet Capital, Limited Partnership
5,500$4800.0%GARPHighBoston, MA2016-11-14